CO19 Sintilimab Plus Chemotherapy for First-Line Treatment of Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer (AMNSQNSCLC): A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.117
https://www.valueinhealthjournal.com/article/S1098-3015(22)00318-7/fulltext
Title : CO19 Sintilimab Plus Chemotherapy for First-Line Treatment of Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer (AMNSQNSCLC): A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00318-7&doi=10.1016/j.jval.2022.04.117
First page :
Section Title :
Open access? : No
Section Order : 10093
Categories :
Tags :
Regions :
ViH Article Tags :